Stockscreener 앱 받기
183.63
0.58%
1.05
시간 외 거래:
183.63
Becton Dickinson Co 주식(BDX)의 최신 뉴스
Becton, Dickinson and Co’s PUREST Study: A New Era in Urine Management - TipRanks
Becton Dickinson Surges to 247th in Trading Volume with $477 Million in Shares Traded - AInvest
Becton, Dickinson and Company (BDX) Fell in Q2 as Earnings Fell Short of Expectations - Insider Monkey
What drives Becton Dickinson and Company stock priceBreakthrough financial growth - jammulinksnews.com
First Pharma Trial Launches for BD Libertas Wearable Injector in $670B Biologics Market | BDX Stock News - Stock Titan
Is Becton Dickinson and Company a good long term investmentBreakthrough financial growth - jammulinksnews.com
Becton Dickinson & Co To Go Ex-Dividend On September 8th, 2025 With 1.04 USD Dividend Per Share - 富途牛牛
Becton Dickinson Investors Seek Final OK Of $9M Deal - Law360
Top Executive Sells Over a Thousand Shares of Becton Dickinson Stock! - TipRanks
Becton Dickinson & Co Slips to 346th in Trading Volume Despite 3.39% Stock Price Gain - AInvest
Jim Cramer Notes Becton Dickinson Stock Recently “Finished in the Black” - MSN
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - MSN
The Smartest Dividend Stock to Buy With $1,000 Right Now - The Motley Fool
Vascular Access Devices Company Evaluation Report 2025 | Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation - Yahoo Finance
BD issues voluntary recall on certain Alaris infusion pump modules - MassDevice
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $190 - 富途牛牛
Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX) - 富途牛牛
Morgan Stanley Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $196 - 富途牛牛
BD issues update to recall of Alaris & BD Alaris pump modules - MarketScreener
BD to spin off biosciences, diagnostics businesses in $17.5B deal (updated) - NJBIZ
Waters to acquire BD flow cytometry business in a deal valued at $17.5 billion - C&EN
Becton Dickinson and : BD Issues Update to Voluntary Global Recall of Alaris™ and BD Alaris™ Pump Modules Serviced with Legacy Bezel Kit Assemblies - MarketScreener
How Do Investors Really Feel About Becton Dickinson? - 富途牛牛
Becton Dickinson stock holds steady as TD Cowen maintains $183 price target By Investing.com - Investing.com South Africa
Becton Dickinson stock holds steady as TD Cowen maintains $183 price target - Investing.com Nigeria
Becton, Dickinson & Co (BDX) Is Paying a $85M Settlement to Investors — Here’s How to Get Your Share - TradingView
Becton, Dickinson and Company (BDX) Traded Down on Weak Earnings - Insider Monkey
Becton, Dickinson and Company: A Solid Divestment For Its Bioscience And Diagnostics Business - Seeking Alpha
Becton Dickinson’s Hold Rating Amid Strategic Moves and Limited Immediate Upside - TipRanks
TD Cowen Initiates Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $183 - 富途牛牛
Waters, BD’s Biosciences & Diagnostic Solutions to combine - Medical Buyer
A Big Move By Waters Corporation And Becton, Dickinson And Company (NYSE:WAT) - Seeking Alpha
William Blair Maintains Becton Dickinson & Co(BDX.US) With Hold Rating - 富途牛牛
BD’s biosciences & diagnostics unit in $17.5B merger with Waters - BioWorld MedTech
$17.5B Deal Combines Waters with BD’s Biosciences and Diagnostics Business - Genetic Engineering and Biotechnology News
Becton Dickinson Announces Reverse Morris Trust with Waters - TipRanks
Becton Dickinson Finds a Partner for Its Biosciences and Diagnostics Business in Waters - Morningstar
Milford’s Waters Corp. strikes $17.5 billion deal to merge with BD’s diagnostics unit - The Boston Globe
Waters to buy Becton Dickinson unit in a $17.5 billion deal amid tariff pressures - CNBC
Waters, BD Unite in $17.5B Diagnostics Deal - USA Herald
Waters, BD Biosciences & Diagnostic Solutions to combine in $17.5B deal - MassDevice
Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal - Investopedia
Waters inks $17.5B merger with division of BD - The Business Journals
Becton Dickinson Spins Off Biosciences In $17.5 Billion Waters Deal - Finimize
Here’s Why Becton, Dickinson and Company (BDX) Traded Lower in Q2 - MSN
Waters, BD Biosciences & Diagnostic Solutions to Merge in $17.5B Deal - Medical Product Outsourcing
Becton Dickinson gets its spinoff deal, but the stock is still falling - MSN
Why is Waters Stock Down On Monday?Becton Dickinson (NYSE:BDX), Waters (NYSE:WAT) - Benzinga
Becton, Dickinson and Company (BDX) Announces Strategic Merger w - GuruFocus
Waters and BD’s Biosciences & Diagnostic Solutions Business To Merge - citybiz
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing - Placera.se
Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal - MarketScreener
Waters to Create $6.5B Life Sciences Giant Through $17.5B Merger with BD Biosciences Division - Stock Titan
Becton, Dickinson and Co. Advances with SiteRite 9 Ultrasound System Study - TipRanks
BD to acquire Bard - The Covington News
BD Appoints Bilal Muhsin as EVP and President of Future Connected Care Segment - citybiz
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment - MarketScreener
0.35%
0.05%
자본화:
|
볼륨(24시간):